首页> 外文期刊>European Journal of Cancer Supplements >Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors S17. Aromatase inhibitors in breast cancer prevention: The IBIS-II trial

【24h】

Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors S17. Aromatase inhibitors in breast cancer prevention: The IBIS-II trial

机译：第6节乳腺癌的一级预防II：使用他莫昔芬，雷洛昔芬和芳香酶抑制剂S17进行化学预防的更新。芳香酶抑制剂在预防乳腺癌中的作用：IBIS-II试验

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2004年第1期|共1页
作者
J.Cuzick;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors S15. The US breast cancer-prevention trials (NSABP-P1, MORE, STAR) [J] . V.Vogel, D.Wickerham, J.Costantino, European Journal of Cancer Supplements . 2004,第1期

机译：第6节乳腺癌的初级预防II：使用他莫昔芬，雷洛昔芬和芳香化酶抑制剂S15进行化学预防的更新。美国预防乳腺癌试验（NSABP-P1，MORE，STAR）
2. Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors S15. The US breast cancer-prevention trials (NSABP-P1, MORE, STAR) [J] . V.Vogel, D.Wickerham, J.Costantino, European Journal of Cancer Supplements . 2004,第1期

机译：第6节乳腺癌的初级预防II：使用他莫昔芬，雷洛昔芬和芳香化酶抑制剂S15进行化学预防的更新。美国预防乳腺癌试验（NSABP-P1，MORE，STAR）
3. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial [J] . Forbes John F., Sestak Ivana, Howell Anthony, The Lancet . 2016,第10021期

机译：Anstrozole与Tamoxifen在绝经后患者中预防局部切除的导管癌原位（Ibis-II DCIS）：双盲，随机对照试验
4. Aromatase Inhibitors in Prevention - Data from the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial and the Design of IBIS-II (the Second International Breast Cancer Intervention Study) [C] . Jack Cuzick International Society of Cancer Chemoprevention . 2003

机译：预防芳族酶抑制剂 - 来自ATAC（ARIMIDEX，Tamoxifen单独或组合或组合的数据）的数据和IBIS-II的设计（第二次国际乳腺癌干预研究）
5. Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs: Pharmacological Evaluation in Phenotypically Diverse Breast Cancer Models and Pharmacokinetic Assessment in Liver Microsome and Female Mouse Models [D] . Hasan, Mahmud. 2020

机译：褪黑激素 - 西昔芬药物缀合物作为乳腺癌药物：在肝微粒和女性小鼠模型中表型多种乳腺癌模型和药代动力学评估的药理评估
6. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind randomised controlled trial [O] . John F Forbes, Ivana Sestak, Anthony Howell, -1

机译：阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防（IBIS-II DCIS）：一项双盲随机对照试验
7. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): A double-blind, randomised controlled trial [O] . Forbes, John F., Sestak, Ivana, Holcombe, Chris, 2016

机译：阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防（IBIS-II DCIS）：一项双盲，随机对照试验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号